CVR number 40829849
Industry 86.9010 Other human health activities

Jette Reichle ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.0% 15.7% 13.3% 16.9% 17.9%  
Credit score (0-100)  0 12 16 9 7  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 31.3 36.1 37.1  
EBITDA  0.0 0.0 15.7 7.9 3.1  
EBIT  0.0 0.0 15.7 7.9 3.1  
Pre-tax profit (PTP)  0.0 0.0 15.6 7.8 3.1  
Net earnings  0.0 0.0 15.6 7.8 -2.8  
Pre-tax profit without non-rec. items  0.0 0.0 15.6 7.8 3.1  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 -5.7 10.0 17.7 15.0  
Interest-bearing liabilities  0.0 17.5 17.5 17.5 0.0  
Balance sheet total (assets)  0.0 21.5 28.8 36.5 36.5  
Net Debt  0.0 13.7 1.2 -6.4 -30.9  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 31.3 36.1 37.1  
Gross profit growth  0.0% 0.0% 0.0% 15.5% 2.9%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 22 29 36 36  
Balance sheet change%  0.0% 0.0% 33.9% 26.6% -0.1%  
Added value  0.0 0.0 15.7 7.9 3.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 50.2% 21.8% 8.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 56.0% 24.1% 8.4%  
ROI %  0.0% 0.0% 69.8% 25.1% 12.2%  
ROE %  0.0% 0.0% 99.4% 56.2% -17.1%  

Solidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% -20.9% 34.6% 48.6% 41.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 7.9% -81.7% -1,005.6%  
Gearing %  0.0% -307.7% 175.5% 98.5% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.2% 0.5% 0.1%  

Liquidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.8 1.5 1.9 1.7  
Current Ratio  0.0 0.8 1.5 1.9 1.7  
Cash and cash equivalent  0.0 3.8 16.2 23.9 30.9  

Capital use efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -5.7 10.0 17.7 15.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 8 3  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 8 3  
EBIT / employee  0 0 0 8 3  
Net earnings / employee  0 0 0 8 -3